GLIVEC 100 MG
imatinib
Public price
11.761,00 MAD
Active substance
imatinib
Laboratory
NOVARTIS PHARMA MAROC
What is this medicine?
Imatinib mesylate is a kinase inhibitor indicated for the treatment of various types of leukemia, myeloproliferative diseases, and specific stromal tumors.
Verified summary
imatinib, Gélule, 100 MG, Boîte de 120
Common uses
Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML),Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL),Myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with platelet-derived growth factor receptor (PDGFR) gene re-arrangements,Aggressive systemic mastocytosis (ASM),Hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL),Unresectable, recurrent and/or metastatic dermatofibrosarcoma protuberans (DFSP),Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumors (GIST),Adjuvant treatment following resection of Kit (CD117) positive GIST
Class
kinase inhibitor
Laboratory
NOVARTIS PHARMA MAROC
Hospital price
11.538,00 MAD
Strength
100 MG
Form
Gélule
Presentation
Boîte de 120
ATC code
L01EA01
Type
Princeps
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-02: 11.761,00 MAD
Available presentations and strengths
Medicines with the same active substance
CEMIVIL 100 MG
100 MG · Boite de 30
848,00 MAD
IMATINIB ZENITH 100 MG
100 MG · Boite de 30
963,00 MAD
CEMIVIL 400 MG
400 MG · Boite de 30
2.010,00 MAD
IMATINIB ZENITH 400 MG
400 MG · Boite de 30
3.016,00 MAD
IMATINIB COOPER 100 MG
100 MG · Boîte de 120
3.500,00 MAD
IMATEC 100 MG
100 MG · Boîte de 120
3.503,00 MAD
IMATEC
100 MG · 1 BOITE 120 GELULE
3.800,00 MAD
IMATINIB COOPER
100 MG · 1 BOITE 120 GELULE
3.800,00 MAD